The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndrome

Journal of Thrombosis and Thrombolysis

Volumn 29, Issue 3, 2010, Pages 303-309

  Diz Kucukkaya, Reyhan ^a   Hancer, Veysel Sabri ^a   Artim Esen, Bahar ^a   Pekcelen, Yuksel ^a   Inanc, Murat ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Antiphospholipid syndrome; Antithrombin deficiency; Factor V Leiden G506A mutation; Protein C deficiency; Protein S deficiency; Prothrombin G20210A mutation; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PHOSPHOLIPID ANTIBODY; PROTHROMBIN; ALANINE; BLOOD CLOTTING FACTOR 5; GLYCINE;

ADOLESCENT; ADULT; ANTIPHOSPHOLIPID SYNDROME; ANTITHROMBIN DEFICIENCY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RISK FACTOR; SCREENING TEST; THROMBOSIS; AMINO ACID SUBSTITUTION; BLOOD; GENETICS; MUTATION; THROMBOPHILIA;

ALANINE; AMINO ACID SUBSTITUTION; ANTIPHOSPHOLIPID SYNDROME; FACTOR V; GLYCINE; HUMANS; MUTATION; PREVALENCE; RISK FACTORS; THROMBOPHILIA;

EID: 77957960397     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-009-0356-9     Document Type: Article

References (25)

1. Wilson WA, Gharavi AE, Koike T et al (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 42:1309-1311. doi: 10.1002/1529-0131 (199907) 42:7<1309::AID-ANR1>3.0. CO;2-F
2. Levine J, Branch W, Rauch J (2002) The antiphospholipid syndrome. N Engl J Med 346:752-763. doi:10.1056/NEJMra002974 (Pubitemid 34983997)
3. Nimmo MC, Carter CJ (2003) The antihospholipid antibody syndrome: a riddle wrapped in a mystery inside an enigma. Clin Appl Immunol Rev 4:125-140. doi:10.1016/S1529-1049 (03) 00 047-3
4. Lockshin MD, Erkan D (2003) Treatment of antiphospholipid syndrome. N Engl J Med 349:1177-1179. doi:10.1056/NEJMe038131 (Pubitemid 37122331)
5. Rosendaal FR (1999) Venous thrombosis: a multicausal disease. Lancet 353:1167-1173. doi:10.1016/S0140-6736 (98) 10266-0
6. Dizon-Townson D, Hutchinson C, Silver R, Branch DW, Ward K (1995) The factor V Leiden mutation which predispose to thrombosis is not common in patients with antiphospholipid syndrome. Thromb Haemost 74:1029-1031
7. Montaruli R, Borchiellini A, Tamponi G et al (1996) Factor V Arg506? Gln mutation in patients with antiphospholipid antibodies. Lupus 5:303-306. doi:10.1177/096120339600500411
8. Fijnheer R, Horbach DA, Donders RC et al (1996) Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus. Thromb Haemost 76:514-517
9. Ames PR, Tommasino C, D'Andrea G, Iannaccone L, Brancaccio V, Margaglione M (1998) Thrombophilic genotypes in subjects with idiophatic antiphospholipid antibodies. Prevalance and significance. Thromb Haemost 79:46-49
10. Pablos JL, Caliz RA, Carreira PE et al (1999) Risk of thrombosis in patients with antiphospholipid antibodies and factor V Leiden mutation. J Rheumatol 26:588-590
11. Galli M, Finazzi G, Duca F, Norbis F, Moia M (2000) The G1691-A mutation of factor V, but not the G20210-A mutation of factor II or the C677-T mutation of methylenetetrahydrofolate reductase genes, is associated with venous thrombosis in patients with venous thrombosis in patients with lupus anticoagulants. Br J Haematol 108:865-870
12. Forastiero R, Martinuzzo M, Adamczuk Y, Varela ML, Pombo G, Carreras LO (2001) The combination of thrombophilic genotypes is associated with definite antiphospholipid syndrome. Haematologica 86:735-741
13. Hansen KE, Kong DF, Moore KD, Ortel TL (2001) Risk factors associated with thrombosis in patients with antiphospholipid antibodies. J Rheumatol 28:2018-2024
14. Chopra N, Koren S, Greer WL et al (2002) Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies. J Rheumatol 29:1683-1688
15. Diz-Küçükkaya R, Demir K, Yenerel MN, Nalçaci M, Kaymakoǧlu S, Inanç M (2002) Coexistence of homozygous factor V Leiden mutation and antiphospholipid antibodies in two patients presented with Budd-Chiari syndrome. Haematologia 32:73-77
16. Ames PR, Margaglione M, Tommasino C, Bossone A, Iannaccone L, Brancaccio V (2001) Impact of plasma homocysteine and prothrombin G20210A on primary antiphospholipid syndrome. Blood Coagul Fibrinolysis 12:699-704
17. Hochberg MC (1997) Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthitis Rheum 40:1725
18. Brandt JT, Triplett DA, Alving B, Scharrer I (1995) Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 74:1185-1190
19. Harris EN (1990) Antiphospholipid antibodies. Br J Haematol 74:1-9
20. Akar N, Akar E, Dalgin G, Sözüöz A, Ömürlü K, Cin Ş (1997) Frequency of factor V (1691 G-A) mutation in Turkish population. Thromb Haemost 78:1527-1528
21. Akar N, Misirlioglu M, Akar E, Avcu F, Yalcin A, Sozuoz A (1998) Prothrombin gene 20210 G-A mutation in the Turkish population. Am J Hematol 58:249
22. Bertina RM, Koeleman BP, Koster T et al (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67
23. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3'-untranslated region of the protrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698-3703
24. De Stefano V, Simioni P, Rossi E et al (2006) The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C, and protein S. Haematologica 91:695-698
25. Torresan M, Machado T F G S, Siqueira LH, Ozelo MC, Arruda VR, Annichino-Bizzacchi JM (2000) The impact of the search for thrombophilia risk factors among antiphospholipid syndrome patients with thrombosis. Blood Coagul Fibrinolysis 11:679-682